(204 days)
SPECTRUM® GV Bone Cement is indicated for the fixation of a REMEDY SPECTRUM® GV Spacer, and for the fixation of prostheses to living bone in the second stage revision of a total hip arthroplasty after the initial infection has been cleared.
SPECTRUM® GV Bone Cement is a radiopaque, PMMA bone cement with gentamicin and vancomycin. The bone cement is single-use and provided sterile. SPECTRUM® GV Bone Cement is a traditional bone cement in that the liquid is contained in a vial and the powder in a sachet. The two components are mixed manually immediately before use. The device is protected from bacterial adhesion due to the presence of gentamicin and vancomycin.
The provided text describes a 510(k) premarket notification for a medical device called "SPECTRUM® GV Bone Cement." This document focuses on the substantial equivalence of the new bone cement to a legally marketed predicate device (SPECTRUM® GV Bone Cement, K172906).
Crucially, this document does NOT describe the acceptance criteria and study proving a device meets acceptance criteria in the context of an AI/Machine Learning (ML) enabled medical device.
The content details the regulatory clearance process for a traditional medical device (bone cement) and the performance testing conducted to demonstrate its physical, chemical, and biological properties, as well as its substantial equivalence to a predicate device.
Therefore, I cannot fulfill the request to provide information about acceptance criteria for an AI/ML device, sample sizes for test sets, expert ground truth, MRMC studies, or training set details from the provided text.
The closest relevant sections in the provided text are "Performance Testing of Subject SPECTRUM® GV Bone Cement," which lists the types of tests performed (mechanical, elution, biocompatibility, sterilization, shelf life), but these are for a physical substance, not a software algorithm.
In summary, the provided document is not about an AI/ML medical device, and thus does not contain the information requested regarding AI/ML device acceptance criteria and validation studies.
§ 888.3027 Polymethylmethacrylate (PMMA) bone cement.
(a)
Identification. Polymethylmethacrylate (PMMA) bone cement is a device intended to be implanted that is made from methylmethacrylate, polymethylmethacrylate, esters of methacrylic acid, or copolymers containing polymethylmethacrylate and polystyrene. The device is intended for use in arthroplastic procedures of the hip, knee, and other joints for the fixation of polymer or metallic prosthetic implants to living bone.(b)
Classification. Class II (special controls). The special control for this device is the FDA guidance document entitled “Class II Special Controls Guidance Document: Polymethylmethacrylate (PMMA) Bone Cement.”